Quick Answer
HARVARD BIOSCIENCE INC reported Stockholders Equity of $13.73 million for fiscal year 2025.
HARVARD BIOSCIENCE INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $13.73M | -78.3% |
| 2024 | $63.34M | -13.3% |
| 2023 | $73.07M | +1.2% |
| 2022 | $72.22M | -13.4% |
| 2021 | $83.40M | +8.8% |
| 2020 | $76.68M | -6.1% |
| 2019 | $81.69M | -1.2% |
| 2018 | $82.72M | +2.3% |
| 2017 | $80.90M | +12.1% |
| 2016 | $72.20M | -7.0% |
| 2015 | $77.60M | -18.7% |
| 2014 | $95.47M | +1.0% |
| 2013 | $94.48M | -9.3% |
| 2012 | $104.21M | +9.1% |
| 2011 | $95.50M | +5.8% |
| 2010 | $90.25M | +19.9% |
| 2009 | $75.26M | +12.8% |
| 2008 | $66.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.07M | -78.5% | -10.6% |
| June 30, 2025 | $15.73M | -76.6% | +6.1% |
| March 31, 2025 | $14.84M | -78.4% | -76.6% |
| December 31, 2024 | $63.34M | -13.3% | -3.0% |
| September 30, 2024 | $65.32M | -12.1% | -2.9% |
| June 30, 2024 | $67.25M | -10.8% | -2.3% |
| March 31, 2024 | $68.81M | -7.4% | -5.8% |
| December 31, 2023 | $73.07M | +1.2% | -1.6% |
- HARVARD BIOSCIENCE INC showed a decrease of -78.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, HARVARD BIOSCIENCE INC’s stockholders equity has declined by 79.4% (from $66.72 million to $13.73 million).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: